Standout Papers
- Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. (1993)
- Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. (1989)
- A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer (2006)
Immediate Impact
14 by Nobel laureates 41 from Science/Nature 151 standout
Citing Papers
100 years of the Warburg effect: A cancer metabolism endeavor
2024 Standout
Co-opting signalling molecules enables logic-gated control of CAR T cells
2023 StandoutNature
Works of Zelig Eshhar being referenced
A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity
2009
Harnessing Syk Family Tyrosine Kinases as Signaling Domains for Chimeric Single Chain of the Variable Domain Receptors: Optimal Design for T Cell Activation
1998
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Zelig Eshhar | 2391 | 4584 | 3666 | 6495 | 176 | 10.8k | |
| Maryalice Stetler‐Stevenson | 1016 | 6069 | 4234 | 8719 | 228 | 15.4k | |
| Winfried S. Wels | 1704 | 4883 | 2664 | 5794 | 174 | 8.8k | |
| Michael C. Milone | 617 | 5721 | 4395 | 11138 | 134 | 15.1k | |
| Michael H. Kershaw | 513 | 6313 | 2717 | 7483 | 130 | 10.7k | |
| Phillip K. Darcy | 582 | 7342 | 3850 | 8943 | 192 | 13.8k | |
| Catia Traversari | 824 | 8200 | 5423 | 5419 | 109 | 12.5k | |
| Hinrich Abken | 560 | 4655 | 2743 | 7742 | 217 | 9.9k | |
| Christoph Rader | 2358 | 1662 | 4036 | 3039 | 179 | 8.4k | |
| Silvana Canevari | 1862 | 2224 | 4311 | 3171 | 225 | 8.6k | |
| Andrew Raubitschek | 4214 | 2156 | 2663 | 4255 | 154 | 8.9k |
All Works
Loading papers...